Found 221 matching trials
Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
PHASE2This study is a randomized, double-blind, placebo-controlled, multi-center,...
Location
Multiple Locations
Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes
PHASE2Human recombinant interleukin-2 (rhIL-2) is a biological signalling protein...
Location
Service d'Endocrinologie Pédiatrique
Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance
PHASE2This study will evaluate the safety and efficacy of a prostate cancer vacci...
Location
Beth Israel Deaconess Medical Center
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
PHASE2This experiment will test the safety and effectiveness of a treatment for m...
Location
National Cancer Institute (NCI)
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
PHASE2Background:
* The National Cancer Institute (NCI) Surgery Branch has devel...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases
PHASE1This is an open label fixed dose phase Ib of anti-CEA CAR-T cells hepatic a...
Location
Roger Williams Medical Center
Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL
PHASE1This is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) comp...
Location
Moffitt Cancer Center
Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors
PHASE1The subject of this study is the adoptive transfer of selected autologous t...
Status
Active Not Recruiting
Location
Providence Portland Medical Center
Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
PHASE2The immune system has offensive and defensive capacities. In bone marrow tr...
Location
Katholieke Universiteit Leuven
Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD
PHASE2Study aims at evaluating the therapeutic efficacy and safety of low-dose IL...
Status
Active Not Recruiting